Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice

Diabetologia

Volumn 39, Issue 5, 1996, Pages 523-529

  Chaillous, L ^a   Darquy, S ^b   Maugendre, S ^c   Rivereau, A S ^a   Reach, G ^b   Sai P ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b HÔTEL DIEU   (France)

^c Laboratory of Histopathology   (France)

Author keywords

diabetes mellitus; hollow fibres; NOD mouse; porcine xenograft; prevention

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SWINE;

EID: 0029866136     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00403298     Document Type: Article

References (36)

1. Thai AC, Eisenbarth GS (1993) Natural history of IDDM. Diabetes Reviews 1: 1-14
2. Castano L, Eisenharth GS (1990) Type 1 diabetes: a chronic autoimmune disease of man, mouse and rat. Annu Rev Immunol 8: 647-679
3. Bowman MA, Leiter EH, Atkinson MA (1994) Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease. Immunol Today 15: 115-120
4. Tarn AC, Thomas JM, Dean BM, Schwartz G, Ingram D, Bottazzo GF, Gale EAM (1992) Predicting insulin-dependent diabetes. Lancet I:845-850
5. Mirouze J, Selam JL, Pham TC, Mendoza E, Orsetti J (1978) Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas Diabetologia 14: 223-227
6. Shah SC, Malone JI, Simpson NE (1989) A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes. N Engl J Med 320: 550-554
7. Atkinson MA, Maclaren NK, Luchetta R (1990) Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39: 933-937
8. Godfredson CF, Buschard K, Frandsen EK (1985) Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 28: 933-935
9. Keller RJ, Eisenbarth GS, Jackson RA (1993) Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 341: 927-928
10. Björk E, Kämpe O, Anderson A et al. (1992) Expression of the 64KDa/glutamic acid decarboxylase rat islet cell autoantigen is influenced by the rate of insulin secretion. Diabetologia 35: 490-493
11. Kämpe O, Andersson A, Björk E, Hallberg A, Karlsson FA (1985) High-glucose stimulation of 64.000-Mr islet cell autoantigen expression. Diabetes 38: 1326-1328
12. Senecat O, Martignat L, Elmansour A, Audrain M, Julien JF, Saï P (1994) Diabetes enhancement and increased islet antigen expression in NOD mice following neonatal injections of glucose and arginine. Metabolism 43: 1-10
13. Sun AM (1988) Microencapsulation of pancreatic islet cells, a bioartificial endocrine pancreas. Methods Enzymol 137: 575-580
14. Reach G (1994) Bioartificial pancreas. Diabet Med 10: 105-109
15. Darquy S, Reach G (1985) Immunoisolation of pancreatic β cells by microencapsulation. An in vitro study. Diabetologia 28: 776-780
16. Fan MY, Lum ZP, Fu XW, Levesque L, Tai IT, Sun AM (1990) Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets. Diabetes 39: 519-522
17. Lacy PE, Hegre OD, Gerasimidi-Vazeou A, Gentile FT, Dionne KE (1991) Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 254: 1782-1784
18. Lum ZP, Tai IT, Krestow M, Norton J, Vacek I, Sun AM (1991) Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets. Diabetes 40: 1511-1516
19. Soon-Shiong P, Feldman E, Nelson R et al. (1993) Long-term reversal of diabetes by the injection of immunoprotected islets. Proc Natl Acad Sci USA 90: 5843-5847
20. Soon-Shiong P, Heintz RE, Merideth N et al. (1994) Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343: 950-951
21. Gianani R, Pugliese A, Bonner-Weir S (1992) Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes 41: 347-353
22. Saï P, Elmansour A, Audrain M, Charbonnel B, Bardet S (1993) Quantification of human islet-cell antibodies which cross-react with mouse pancreas: a follow-up study in type 1 diabetic patients and in first-degree relatives. Diabetologia 36: 778-784
23. r 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM. Diabetologia 37: 491-499
24. r 64,000 protein, and antibodies to intact glutamate decarboxylase, in type 1 diabetic patients. Diabetes Care 17: 1115-1123
25. Chicheportiche D, Darquy S, Lepeintre J, Capron F, Halban PA, Reach G (1990) High-performance liquid chromatography analysis of circulating insulins distinguishes between endogenous insulin production (a potential pitfall with streptozotocin diabetic rats) and islet xenograft function. Diabetologia 33: 457-461
26. Arbet-Engels C, Darquy S, Capron F, Reach G (1993) Isolation of islets of Langerhans from the rat and pig pancreas using a modified UW solution from organ storage to islet purification. Diabete Metab 19: 590-596
27. Honiger J, Darquy S, Reach G, Muscat E, Thomas M, Collier C (1994) Preliminary report on cell encapsulation in a hydrogel made of biocompatible material AN69 for the development of a bioartificial pancreas. Int J Artif Organs 17: 46-52
28. Chaillous L, Darquy S, Maugendre S et al. (1995) Reversal of diabetes in NOD mice by xenografts of porcine islets immunoprotected into a new hollow fibre. Diabete Metab 21: 48 (Abstract)
29. Baekkeskov S, Aanstoot HK, Christgau S et al. (1990) Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156
30. Martignat L, Elmansour A, Audrain M, Julien JF, Charbonnel B, Saï P (1995) Pancreatic expression of antigens for islet cell antibodies in non-obese diabetic mice. J Autoimmun 8: 465-482
31. Wicker LS, Miller BJ, Mullen Y (1986) Transfer of autoimmune diabetes mellitus with splenocytes from non-obese diabetic (NOD) mice. Diabetes 35: 855-860
32. Genovese S, Bonifacio E, McNally J et al. (1992) Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35: 385-388
33. Nayac RC, Omar MAK, Rabizadeh A, Srikanta S, Eisenbarth GS (1985) 'Cytoplasmic' islet cell antibodies: evidence that the target antigen is a sialoglycoconjugate. Diabetes 34: 617-619
34. Atkinson MA, Kaufman DL, Newman D, Tobin AJ, Maclaren NK (1993) Islet cell cytoplasmic antibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest 91: 350-356
35. Velloso LA, Kämpe O, Eizirik DL, Hallberg A, Anderson A, Karlsson FA (1993) Human autoantibodies react with glutamic acid decarboxylase antigens in human and in rat but not in mouse islets. Diabetologia 36: 39-46
36. Serreze DV, Leiter EH, Kuff EL, Jardieu P, Ishizaka K (1988) Molecular mimicry between insulin and retroviral antigen p73: development of cross-reactive autoantibodies in sera of NOD and C57BL/KsJ db/db mice. Diabetes 37: 351-358